genedrive plc

("genedrive" or the "Company")

Result of AGM

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that at the Annual General Meeting, held today, all resolutions proposed were duly passed.

For information, details of the proxy voting are shown below:

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website (www.genedriveplc.com).

Although all the resolutions were passed, the Board of genedrive notes that more than 20% of votes were cast against the reappointment of certain directors and the resolution to generally disapply pre-emption rights (subject to certain limits).  While the Board believes that all these directors bring considerable experience and expertise to the Board, it intends to engage with shareholders to better understand their concerns on the resolutions.

For further details please contact: